Could Resistant Starch Help in Parkinson’s Disease Treatment?

Could Resistant Starch Help in Parkinson’s Disease Treatment? A groundbreaking clinical trial reveals how a simple dietary supplement — by reshaping your gut microbiome — can measurably reduce both the motor and non-motor symptoms of Parkinson’s disease.

Key Findings at a Glance

• Microbiome Restored: Resistant starch increased beneficial Faecalibacterium species and reduced harmful opportunistic pathogens
• Symptoms Improved: All clinical Parkinson’s scales — motor and non-motor — showed significant improvement after long-term use
• Inflammation Reduced: Blood levels of anti-inflammatory protein APOA4 and neuroprotective HSPA5 both rose significantly
• SCFAs Boosted: Total short-chain fatty acids (including acetate) — critical gut-health molecules — increased measurably in stool

What Just Happened in Parkinson’s Research?

In early 2026, a team of researchers from Luxembourg, Germany, and the United Kingdom published a landmark study in the prestigious journal Brain, Behavior, and Immunity — and the findings have significant implications not just for Parkinson’s disease, but for anyone interested in gut health and its profound influence on the brain.

The study found that supplementing with resistant starch — a type of dietary fibre found in foods like cooked and cooled potatoes, green bananas, and legumes — significantly changed the composition of the gut microbiome in people with Parkinson’s disease. More remarkably, these microbiome changes translated into real, measurable improvements in symptoms.

This is the kind of research that reinforces something we at Healthpath have long championed: the health of your gut is inextricably linked to the health of your brain. Your gut isn’t just digesting food — it’s actively communicating with your nervous system, regulating inflammation, and influencing the progression of some of the most serious neurological conditions we know of.

“The gut microbiome in Parkinson’s disease is altered in ways that promote neuroinflammation and worsen symptoms — and this study shows we can change that trajectory with targeted nutrition.”

The Gut–Brain Connection in Parkinson’s Disease

Before we dive into what resistant starch does, it helps to understand why the gut matters so much in Parkinson’s disease (PD) in the first place.

PD is the world’s second most common neurodegenerative disease. Most people know it by its motor symptoms — tremor, rigidity, and slowness of movement — but the disease actually begins in the gut, often years before any brain symptoms appear. Constipation, loss of smell, and fatigue are some of the earliest warning signs, rooted in gut-brain miscommunication.

Research consistently shows that people with PD have a distinctly altered gut microbiome — one characterised by a significant depletion of beneficial bacteria that produce short-chain fatty acids (especially Faecalibacterium), alongside an increase in opportunistic pathogens and pro-inflammatory microbes. This creates a “leaky gut,” allowing bacterial products to enter the bloodstream and travel to the brain — fuelling the neuroinflammation that drives disease progression.

This isn’t a minor side issue. It is now understood to be a core feature of how Parkinson’s disease develops and progresses. And it opens a crucial door: if we can change the gut microbiome, can we slow — or even partially reverse — disease progression?

This new clinical trial set out to answer exactly that question.

About the Study: What Did They Actually Do?

This was a rigorous, randomised, controlled clinical trial involving 74 people with confirmed Parkinson’s disease. Participants were randomly assigned to one of three groups for an initial two-week (short-term) phase: a conventional (mixed) diet group, a resistant starch supplement group (receiving 5g of resistant starch type 3, three times daily with meals), and a high-fibre vegetarian diet group.

What made this study especially valuable was the long-term follow-up. A subset of the resistant starch group continued for a full 40 weeks of active supplementation, followed by an 8-week washout period — giving researchers an unprecedented look at sustained effects.

Throughout the study, participants underwent thorough assessment of their gut microbiome (via advanced DNA sequencing of stool), their stool metabolites (what their gut bacteria were producing), their blood inflammatory proteins, and their Parkinson’s symptoms using multiple validated clinical scales.

A note on study design: While the results are compelling, the long-term arm did not have a contemporaneous control group — participants in the control group were assessed at baseline only. This is a recognised limitation the authors themselves note, and it means we should interpret the long-term findings with appropriate care while awaiting further, larger-scale replication studies.

What Happened to the Gut Microbiome?

The microbiome changes observed were striking, and they align with what we know about what a healthy gut should look like.

The Rise of Faecalibacterium

Perhaps the most clinically significant finding was the substantial increase in Faecalibacterium species in people taking the resistant starch supplement. Faecalibacterium is one of the most important bacteria in the healthy human gut. It is a major producer of butyrate — an anti-inflammatory short-chain fatty acid that protects the gut lining, reduces intestinal permeability, and has documented neuroprotective properties.

Faecalibacterium is known to be depleted in people with Parkinson’s disease. This study showed that targeted feeding — in the form of resistant starch — can reliably restore it.

The Decline of Harmful Bacteria

At the same time, several bacteria known to cause harm decreased significantly. Streptococcus anginosus — an opportunistic pathogen linked to gastrointestinal infections — declined in the high-fibre group. Enterocloster bolteae — associated with gut dysbiosis in multiple sclerosis, inflammatory bowel disease, and autism spectrum disorders — decreased in both intervention groups. Members of Actinomyces — previously shown to be elevated in Parkinson’s — also fell.

How Resistant Starch Reshapes Your Gut: The Step-by-Step Mechanism

Step 1 — Resistant starch reaches your large intestine undigested. Unlike regular starch, resistant starch passes through the stomach and small intestine intact — arriving in the colon as a rich food source for your gut bacteria.

Step 2 — Beneficial bacteria ferment it and multiply. Bacteria like Faecalibacterium feast on resistant starch, growing in number and producing short-chain fatty acids (SCFAs) — particularly acetate and butyrate — as they do so.

Step 3 — SCFAs heal the gut lining and reduce inflammation. Short-chain fatty acids strengthen intestinal barrier integrity, reducing “leaky gut” — a key driver of systemic inflammation in Parkinson’s disease.

Step 4 — Anti-inflammatory signals reach the brain. Via the gut-brain axis, reduced gut inflammation translates to lower neuroinflammation — which is directly linked to slower progression of Parkinson’s symptoms.

Could your gut benefit? Test, don't guess.

Shop our gut health tests

The Metabolite Story: What Your Gut Was Making

One of the most sophisticated aspects of this study was the detailed analysis of what the gut microbiome was actually producing — and how that changed with dietary intervention.

Short-Chain Fatty Acids Increased

Total SCFAs, and specifically acetate, increased significantly in the stool of people taking resistant starch over the long term. SCFAs serve as fuel for the cells lining your colon, act as signalling molecules that regulate immune function, and play a direct role in maintaining the blood-brain barrier. People with Parkinson’s disease are known to have reduced SCFA levels — this study shows that a targeted dietary intervention can restore them.

Pyroglutamic Acid Rose

Resistant starch supplementation was associated with an increase in pyroglutamic acid — a compound previously reported to be decreased in people with Parkinson’s. This is particularly interesting because pyroglutamic acid stimulates the release of GABA and acetylcholine, two neurotransmitters that are disrupted in PD.

Erythronic Acid Fell

Erythronic acid — a biomarker of mitochondrial dysfunction — decreased in those taking the supplement. Since mitochondrial dysfunction is considered a hallmark of Parkinson’s disease pathology, this may indicate that the dietary intervention was achieving measurable improvements at the cellular energy production level.

The Inflammation Connection: Blood Markers That Changed

Beyond the gut, the long-term intervention produced measurable changes in the blood — specifically in two proteins that have significant implications for brain health.

APOA4: A Natural Anti-Inflammatory

Apolipoprotein A-IV (APOA4) rose significantly in people taking resistant starch long-term. APOA4 is produced in the intestine and liver and is known for its powerful anti-inflammatory properties — it limits the production of pro-inflammatory cytokines like TNF-α and IFN-γ. In this study, higher APOA4 levels were directly associated with improvements in non-motor Parkinson’s symptoms and quality of life.

APOA4 is also linked to Alzheimer’s disease — lower APOA4 expression is found in people with Alzheimer’s, and animal models show that APOA4 knockout worsens disease progression. This suggests a broader neuroprotective role for this protein in neurodegeneration.

HSPA5: The Brain’s Stress Responder

Heat shock protein HSPA5 (also known as GRP78) also rose in the supplement group. HSPA5 is a chaperone protein — it helps misfolded proteins in the cell get correctly shaped or safely disposed of. Misfolded alpha-synuclein protein is the defining feature of Parkinson’s disease pathology, and HSPA5 has been shown in multiple studies to reduce alpha-synuclein toxicity and suppress the microglial inflammation that damages dopaminergic neurons.

The fact that a dietary intervention — resistant starch — was able to increase blood levels of this neuroprotective protein is a genuinely exciting finding. It suggests a plausible molecular pathway by which gut health improvements translate into brain health improvements.

Did Symptoms Actually Improve? Yes — Across the Board.

After long-term resistant starch supplementation, participants showed significant improvement across all measured clinical scales:

• Motor symptoms (MDS-UPDRS Parts II & III): Significant reduction in the severity and progression of motor impairment. The Part III scale — which involves direct clinical examination of motor function — showed a significant decreasing trend throughout the intervention period.
• Non-motor symptoms (MDS-UPDRS Part I, NMSQ, NMSS): Significant improvements in non-motor features like cognitive impairment, fatigue, and autonomic dysfunction.
• Quality of life (PDQ-39): Participants reported measurably better quality of life, particularly in areas linked to APOA4 blood levels.

Crucially, no adverse events were reported across the entire study. Resistant starch is safe, widely available, and well-tolerated.

What Exactly Is Resistant Starch?

Resistant starch (RS) is a form of starch that, as the name suggests, resists digestion in the small intestine. Instead of being broken down and absorbed as glucose, it passes through to the large intestine where it acts as a prebiotic — food for your gut bacteria. The study used resistant starch type 3, which forms when starchy foods are cooked and then cooled (known as retrograde resistant starch).

Foods naturally rich in resistant starch include:

• Cooked and cooled potatoes
• Green (unripe) bananas
• Cooked and cooled rice
• Cooked and cooled pasta
• Legumes and lentils
• Oats (especially cooled overnight oats)
• Plantains
• Cashews

Note: The study used a commercial resistant starch supplement to achieve standardised, therapeutic doses. Dietary sources alone may provide lower amounts.

What This Means for You

If You Have Parkinson’s Disease

This study adds meaningful evidence that dietary intervention — specifically resistant starch supplementation — is worth discussing with your neurologist and a gut health specialist. The effects took time (the most dramatic clinical improvements were seen in the long-term arm), which is consistent with how microbiome remodelling works. This is not a quick fix, but it may be a profoundly important adjunct to standard care.

If You Have a Family History of Parkinson’s or Other Neurological Conditions

Given what we know about the early gut involvement in PD — with gut dysbiosis appearing years before motor symptoms — there is a compelling case for proactive gut health optimisation as a preventive strategy. Knowing the state of your gut microbiome is the essential first step.

If You Simply Want to Protect Your Brain as You Age

The mechanisms described in this study — SCFA production, reduced intestinal permeability, increased APOA4 and HSPA5, better microbial community signalling — are relevant to brain health broadly, not just Parkinson’s disease. A gut microbiome rich in SCFA-producing bacteria is associated with lower systemic inflammation, better cognitive function, and reduced risk of multiple chronic diseases.

Frequently Asked Questions

Can resistant starch cure Parkinson’s disease? No. This study demonstrates that resistant starch supplementation can significantly improve symptoms and modify relevant biological pathways, but it is not a cure. Parkinson’s disease is a complex, multifactorial condition. Dietary intervention is best understood as a powerful complement to — not a replacement for — conventional medical treatment.

How much resistant starch was used in the study? During the short-term phase, participants took 5g of resistant starch type 3 three times daily with meals (15g per day total). During the long-term outpatient phase, this was reduced to 5g twice daily (10g per day). The supplement also contained isomaltulose, glucomannan, silicon dioxide, Stevia, and biotin.

What is SIBO and could it be affecting my gut microbiome? Small Intestinal Bacterial Overgrowth (SIBO) is a condition where bacteria proliferate in the small intestine — where they shouldn’t be in large numbers. SIBO can disrupt digestion, cause bloating and discomfort, and fundamentally alter your gut microbiome in ways that overlap with the dysbiosis seen in inflammatory and neurological conditions. Testing for SIBO is a key part of a comprehensive gut health assessment.

How do I know if my gut microbiome is healthy? The only way to know with confidence is to test it. A comprehensive gut microbiome analysis provides a detailed picture of which bacteria are present, in what proportions, and what they are producing — including whether key SCFA-producing species like Faecalibacterium are present at healthy levels. This is the foundation of targeted, evidence-based gut health intervention.

Should I start taking resistant starch supplements? If you have Parkinson’s disease, discuss this research with your neurologist or a nutritional therapist/functional medicine practitioner. For general gut health optimisation, increasing dietary resistant starch through food sources is a safe, evidence-supported strategy. If you have existing digestive conditions such as SIBO or inflammatory bowel disease, work with a gut health specialist before substantially increasing fibre intake, as this can sometimes exacerbate symptoms in the short term.

The Bottom Line

This study represents a significant step forward in our understanding of the gut-brain axis and its therapeutic potential. Published in one of the leading journals in the field, the research demonstrates — with rigorous multi-omics methodology — that feeding the right bacteria can lead to meaningful improvements in one of the most serious neurological diseases in the world.

The pathway is clear: resistant starch feeds beneficial bacteria → beneficial bacteria produce anti-inflammatory SCFAs → gut inflammation decreases → systemic and neurological inflammation decreases → symptoms improve. And this is not a theoretical pathway. It was measured, in human patients, across multiple biological layers.

Understanding your unique gut microbiome is not a luxury — it is the foundation of long-term health. Whether you are managing a neurological condition, concerned about your risk, or simply committed to ageing well, the gut is where the conversation needs to start.

---

Reference: Petrov VA, Schade S, Laczny CC, et al. Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammation. Brain, Behavior, and Immunity. 2026;132:106217.

This article is for informational and educational purposes only and does not constitute medical advice. Always consult your physician before making changes to your diet, supplement routine, or treatment plan.